Likewise, Song et al. (2022) reported in patients with epilepsy from Yunnan Province, China, that the frequencies of CYP2C19*2 and CYP2C19*3 were 33.1% and 3%, respectively, among patients receiving VPA treatment [51]. This evidence concerns the gene CYP2C19 and epilepsy.